IRIS
CANNAVO', Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.096
EU - Europa 5.291
AS - Asia 1.887
SA - Sud America 11
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
AF - Africa 3
Totale 13.301
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.070
IE - Irlanda 1.510
SE - Svezia 1.179
CN - Cina 975
IT - Italia 773
SG - Singapore 719
UA - Ucraina 391
PL - Polonia 356
DE - Germania 351
FI - Finlandia 250
GB - Regno Unito 209
FR - Francia 115
IN - India 71
VN - Vietnam 56
BE - Belgio 42
ID - Indonesia 28
RU - Federazione Russa 27
AT - Austria 22
CZ - Repubblica Ceca 22
CA - Canada 20
NL - Olanda 12
JP - Giappone 10
AU - Australia 7
CL - Cile 4
ES - Italia 4
EU - Europa 3
NO - Norvegia 3
PH - Filippine 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AR - Argentina 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
GR - Grecia 2
HK - Hong Kong 2
HR - Croazia 2
HU - Ungheria 2
IL - Israele 2
IQ - Iraq 2
KR - Corea 2
LK - Sri Lanka 2
LT - Lituania 2
MD - Moldavia 2
MX - Messico 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
RO - Romania 2
RS - Serbia 2
SA - Arabia Saudita 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
CO - Colombia 1
EC - Ecuador 1
EE - Estonia 1
IR - Iran 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 13.301
Salva come PNG Salva come JPEG
Città #
Dublin 1.509
Chandler 1.236
Jacksonville 914
Nyköping 695
Singapore 592
Beijing 377
Warsaw 355
Ashburn 323
Messina 299
Princeton 290
Dearborn 274
Medford 234
Cambridge 228
Des Moines 203
Ann Arbor 136
Boardman 131
Lancaster 110
Wilmington 88
New York 77
Shenyang 72
Jinan 63
San Mateo 60
Los Angeles 59
Nanjing 58
Dong Ket 56
Munich 46
Tianjin 45
Helsinki 43
Hyderabad 43
Woodbridge 42
Brussels 39
Haikou 39
Seattle 38
Hebei 35
Bremen 30
Hangzhou 29
Jakarta 28
Zhengzhou 27
Nanchang 26
Houston 25
Ningbo 25
Catania 23
Rome 23
Guangzhou 22
Pune 21
Turin 20
Vienna 20
Falls Church 18
Taizhou 17
Washington 16
Fuzhou 15
Strasbourg 13
Clearwater 12
Ottawa 11
Brno 10
Changsha 10
Milan 9
Norwalk 9
Redmond 9
Frankfurt am Main 8
Lanzhou 8
Olomouc 8
Palermo 8
Carrara 7
Edinburgh 7
Jiaxing 7
Saint Petersburg 7
Fairfield 6
Lappeenranta 6
Reggio Calabria 6
Shanghai 6
Tappahannock 6
Tokyo 6
Auburn Hills 5
Bologna 5
Brescia 5
Kunming 5
London 5
Sydney 5
Toronto 5
Florence 4
Genova 4
Greifswald 4
Las Vegas 4
Parma 4
Riva 4
Taiyuan 4
Vittoria 4
Augusta 3
Bari 3
Capri Leone 3
Cluses 3
Council Bluffs 3
Floridia 3
Fremont 3
Kemerovo 3
Madrid 3
Marburg 3
Montale 3
Mumbai 3
Totale 9.476
Salva come PNG Salva come JPEG
Nome #
La chirurgia tiroidea transorale 152
Cardiovascular outcomes and conventional risk factors in nondiabetic adult patients with GH deficiency: a long-term retrospective cohort study 109
Clinical management of critically ill patients with Cushing's disease due to ACTH-secreting pituitary macroadenomas: effectiveness of presurgical treatment with pasireotide 106
ACROSCORE: a new and simple tool for the diagnosis of acromegaly, a rare and underdiagnosed disease 104
Diabetes secondary to acromegaly: Physiopathology, clinical features and effects of treatment 100
Acromegaly is more severe in patients with AHR or AIP gene variants living in highly polluted areas 95
Aggressive pituitary adenomas: the dark side of the moon 91
Cyberknife stereotactic treatment of pituitary adenomas: A single center experience using different irradiation schemes and modalities 88
L’apoplessia ipofisaria: riconoscerla rapidamente e trattarla correttamente. 87
A 53-year-old woman with Cushing's disease and a pituitary tumor 84
Acromegaly is associated with increased cancer risk: a survey in Italy 83
Characteristics of a nationwide cohort of patients presenting with isolated hypogonadotropic hypogonadism (IHH) 83
Commentary on "Co-Occurrence of Pituitary Adenoma With Suprasellar and Olfactory Groove Meningiomas" 80
GSTP1 gene methylation and AHR rs2066853 variant predict resistance to first generation somatostatin analogs in patients with acromegaly 79
Acne ed irsutismo: patologie endocrine? 78
Trattamento di tumori ipofisari mediante Cyber-Knife: Dati preliminari a medio termine su efficacia e sicurezza 78
The role of inferior petrosal sinus sampling in ACTH-dependent Cushing's syndrome: review and joint opinion statement by members of the Italian Society for Endocrinology, Italian Society for Neurosurgery, and Italian Society for Neuroradiology 78
Course of Pregnancy in Cushing Disease under Different Management Approaches (No Treatment, Surgery, Gamma-Knife or Ketoconazole) 77
Deficit di ormone della crescita e sindrome metabolica: effetti del trattamento sostitutivo a lungo termine con GH ricombinante in età adulta. 75
PRIMARY EMPTY SELLA IS ASSOCIATED WITH INCREASED CARDIOVASCULAR RISK, REGARDLESS THE OCCURRENCE OF PITUITARY DYSFUNCTION 75
P-57 Increased prevalence of acromegaly in an industrialized area of north-east of Sicily: a case-control study 75
Peptide receptor radionuclide therapy with 111IN-DTPA-Octreotide in a woman with Cabergoline-resistant giant prolactinoma 74
Increased prevalence of acromegaly in a highly polluted area. 73
Multidisciplinary management of pituitary apoplexy 71
MRI finding of simultaneous coexistence of growth hormone-secreting pituitary adenoma with intracranial meningioma and carotid artery aneurysms: report of a case 69
Resistance to somatostatin analogues is associated with GSTP1 gene methylation and AHR rs2066853 variant in acromegaly patients 68
Epidemiologia degli adenomi ipofisari nel nord-est della Sicilia 67
Effectiveness and safety of long-term pegvisomant administration in patients with acromegaly not controlled by other therapies: experience of an Italian center. 67
Markers di aterosclerosi precoce nei vasi carotidei e femorali in pazienti acromegalici 66
Abnormalities of hypothalamic-pituitary-thyroid axis in patients with primary empty sella 66
Modificazione del pattern secretivo, dopo chirurgia, e dei marker proliferativi cellulari, dopo radioterapia (gamma-knife), in un corticotropinoma invasivo. 66
Acromegaly and coronary disease: An integrated evaluation of conventional coronary risk factors and coronary calcifications detected by computed tomography 66
Predictive markers of recurrence in radically resected pituitary macroadenomas 66
Increased prevalence of restless legs syndrome in patients with acromegaly and effects on quality of life assessed by Acro-QoL. 66
Increased serum interleukin-22 levels in patients with PRL-secreting and non-functioning pituitary macroadenomas. 66
Cardiovascular events in acromegaly: distinct role of Agatston and Framingham score in the 5-year prediction. 66
Thyroid nodules in growth hormone replaced patients. 66
Non-functioning pituitary adenomas infrequently harbor G-protein gene mutations. 65
Effects of GH replacement therapy on thyroid volume and nodule development in GH deficient adults: a retrospective cohort study 65
First report on persistent remission of acromegaly after withdrawal of long-term pegvisomant monotherapy 65
Acromegalic cardiopathy: a morphofunctional study with color-Doppler echocardiography 65
XANTHOMA DISSEMINATUM WITH HYPOTHALAMUS-PITUITARY INFILTRATION AND PARTIAL HYPOPITUITARISM 64
Abnormal daily periodicity of serum thyrotropin (TSH) and evidencefor defective TSH suppression in a case of non-neoplastic syndrome ofinappropriate TSH secretion. 64
Analisi dell'intervallo QT all'ECG di superficie in pazienti affetti da deficit primario di GH con e senza ipertrofia ventricolare sinistra 64
Conventional and nuclear medicine imaging in Ectopic Cushing's syndrome: a systematic review 64
Acromegaly, genetic variants of the aryl hydrocarbon receptor pathway and environmental burden 64
Abnormalities of GH secretion in a young girl with Floating-Harbor syndrome 63
Temozolomide-induced shrinkage of a pituitary carcinoma causing Cushing's disease--report of a case and literature review. 63
Effects of pasireotide treatment on cardio-metabolic risk in patients with Cushing's disease: an Italian, multicenter study 63
Peptide receptor radionuclide therapy for aggressive pituitary tumors: a monocentric experience 63
Dissociated responsiveness of a growth hormone- and thyrotropin-secreting pituitary adenoma to octreotide-long-acting release therapy: The intriguing case of Mister B. 62
Atrial parasystole in left ventricular noncompaction: a morphofunctional study by echocardiography and magnetic resonance imaging. 61
Increased frequency of the rs2066853 variant of aryl hydrocarbon receptor gene in patients with acromegaly 61
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment 61
Global epidemiology of acromegaly: A systematic review and meta-analysis 61
Dioxin-like pentachlorobiphenyls promote extra-cellular matrix remodeling by increasing the expression of endothelial cell-specific molecule 1 and metalloproteinases, and induce epigenetic modifications in thyrocytes 60
Shrinkage of a PRL-secreting pituitary macroadenoma resistant to cabergoline 60
Pattern of Use of Biosimilar and Originator Somatropin in Italy: A Population-Based Multiple Databases Study During the Years 2009-2014 60
Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas. 59
Valutazione dell'asse ipotalamo-ipofisi-tiroide e del volume tiroideo in pazienti acromegalici 59
Spontaneous intermittent MRI changes of a pituitary stalk lesion causing diabetes insipidus and amenorrhea 59
Oxidative stress as a key feature of autoimmune thyroiditis: an update 59
Evaluation of myocardial fibrosis by imaging techniques in acromegaly. 58
First demonstration of the effectiveness of peptide receptor radionuclide therapy (PRRT) with 111In-DTPA-octreotide in a giant PRL-secreting pituitary adenoma resistant to conventional treatment. 58
An extremely rare association of TSH-secreting pituitary adenoma, metastatic neuroendocrine tumor and Cushing’s syndrome in a patient with MEN-1 gene mutation 58
Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas 58
Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study. 57
Therapy for the syndromes of GH excess 57
Alterazioni della funzionalità tiroidea in pazienti con sindrome della sella vuota primaria 57
Lymphocytic hypophysitis: differential diagnosis and effects of high-dose pulse steroids, followed by azathioprine, on the pituitary mass and endocrine abnormalities--report of a case and literature review. 57
N-terminal pro-brain natriuretic peptide determination as a possible marker of cardiac dysfunction in patients with adrenal disorders 57
Effects of cyberknife radiotherapy treatment of pituitary adenomas 57
Vitamin D receptor gene polymorphisms/haplotypes and serum 25(OH)D3 levels in Hashimoto's thyroiditis. 57
HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. 57
Biochemical control and clinical improvement is induced by long-term pasireotide administration in the majority of patients with Cushing[apos]s disease persistent after pituitary surgery 57
Subcutaneous lipoatrophy induced by long-term pegvisomant administration 56
Hypophosphatemia as unusual cause of ARDS in Cushing's syndrome secondary to ectopic CRH production. A case report 56
TREATMENT OF PITUITARY TUMOURS BY CYBERKNIFE: PRELIMINARY DATA OF MIDDLE-TERM EFFECTIVENESS AND SAFETY 56
A case of clinically silent acromegaly with erectile dysfunction. 56
Pitfalls in the 2017 TNM Classification of Thyroid Carcinoma 56
High bone marrow fat in patients with Cushing’s syndrome and vertebral fractures 55
Early-onset cerebellar ataxia, myoclonus and hypogonadism in a case of mitochondrial complex III deficiency treated with vitamins K3 and C 54
Mitotane treatment in patients with adrenocortical cancer causes central hypothyroidism 54
Analysis of GPR101 and AIP genes mutations in acromegaly: a multicentric study 54
The boxer world heavyweight champion Primo Carnera portrayed by Giacomo Balla 54
Endocrine and metabolic adverse effects of immune checkpoint inhibitors: an overview (what endocrinologists should know) 54
Clinical presentation and outcome of pituitary adenomas in teenagers 54
Twelve months of treatment with octreotide LAR reduces joint thickness in acromegaly 53
Abnormal responses to vasoactive intestinal peptide and corticotropin releasing hormone during thespontaneous remission of Cushing's disease. 53
Visceral adiposity index as an indicator of cardiometabolic risk in patients treated for craniopharyngioma 53
Comment to ‘glucocorticoid resistance syndrome caused by a novel nr3c1 point mutation’ by al argan et al. 53
Linee di Consenso diagnostico-terapeutico: le iperprolattinemie 52
Modificazione dei parametri di rischio cardiovascolare durante trattamento sostitutivo prolungato con ormone della crescita 52
Imaging in endocrinologia: descrizione di un caso di cardiopatia acromegalica e fibrosi miocardica dimostrata in vivo mediante RMN 52
Gigantismo e acromegalia causati da microduplicazioni del locus Xp26 e da mutazione del gene GPR101 52
SIMULTANEOUS COEXISTENCE OF GH-SECRETING PITUITARY ADENOMA, MENINGIOMA AND CAROTID ARTERY ANEURYSM 52
Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity 52
Dopamine D(2) receptor gene polymorphisms and response to cabergoline therapy in patients with prolactin-secreting pituitary adenomas. 51
Severe head trauma in patients with unexplained central hypothyroidism 51
Temozolomide-induced shrinkage of a pituitary carcinoma. 51
Totale 6.595
Salva come PNG Salva come JPEG
Categoria #
all - tutte 63.466
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.466
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020958 0 0 0 0 0 0 210 172 42 252 264 18
2020/20212.040 165 34 420 117 163 342 160 164 136 162 72 105
2021/20221.699 15 219 31 95 50 23 85 75 41 205 243 617
2022/20234.670 394 357 202 384 323 477 88 295 1.847 47 197 59
2023/20241.199 111 213 98 108 111 212 20 104 4 65 7 146
2024/20251.138 101 83 162 316 337 139 0 0 0 0 0 0
Totale 14.020